glp-1 drugs and thyroid cancer Increased screening may lead to higher risk after initiation GLP-1 Medications & Thyroid Cancer
Description
Early results indicate about 10-25% of users experience minimal weight loss or even slight weight gain
Br J Pharmacol 2022;179(4):557570
Nakamaru Y, Akahoshi F, Iijima H, Hisanaga N, Kume T
Another review looked at how well different GLP-1 receptor agonists worked when added to metformin in people with type 2 diabetes
A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
Recent advances in dipeptidyl-peptidase-4 inhibition therapy: lessons from the bench and clinical trials
